Update: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Practice Guideline, April 2016
Read Published ArticleIn 2008, the 好色先生 (AAN) published guidelines on the uses of botulinum neurotoxin (BoNT). New research on 4 indications—blepharospasm, cervical dystonia (CD), spasticity, and headache—prompted this update.
Retired on April 7, 2025.
Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and the American Society of Plastic Surgeons.
Clinician Tools and Materials
Companion Publication - Botulinum Neurotoxin - Policy Perspectives
Download a companion piece to this guideline productCompanion Publication - Botulinum Neurotoxin - Gaps in Knowledge
Download a companion piece to this guideline product好色先生al Materials
Other resources related to this guideline